Effect of Vitamin D and Skeletal Muscle Mass on Prognosis of Patients with Diffuse Large B-Cell Lymphoma

Autor: Nobuhiko Nakamura, Nobuhiro Kanemura, Takuro Matsumoto, Hiroshi Nakamura, Yuhei Shibata, Kimihiro Yamaguchi, Junichi Kitagawa, Yoshikazu Ikoma, Tomomi Suzaki, Yuto Kaneda, Soranobu Ninomiya, Eri Takada, Takeshi Hara, Hisashi Tsurumi, Masahito Shimizu
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: Nutrients, Vol 16, Iss 16, p 2653 (2024)
Druh dokumentu: article
ISSN: 2072-6643
DOI: 10.3390/nu16162653
Popis: This study investigated the prognostic impact of vitamin D deficiency and reduced skeletal muscle mass in diffuse large B-cell lymphoma (DLBCL) patients. A retrospective analysis of 186 newly diagnosed DLBCL patients from 2012 to 2022 was conducted, measuring serum 25-hydroxyvitamin D [25(OH)D] levels and the skeletal muscle index (SMI). Decreased vitamin D levels were linked to more severe DLBCL disease, with a median 25(OH)D concentration of 13 (4.0–27) ng/mL. Males in the group with a low SMI had a considerably lower 25(OH)D concentration. The optimal threshold of 25(OH)D levels for overall survival (OS) was 9.6 ng/mL, with lower values associated with a higher likelihood of recurrence and mortality. Multivariable analysis showed hazard ratios for OS of 1.4 [95% CI 0.77–2.5] for a low SMI and 3.2 [95% CI 1.8–5.8] for low 25(OH)D concentration. The combination of a low SMI and low vitamin D concentration resulted in the worst prognosis. Thus, low levels of vitamin D associated with disease progression significantly impact DLBCL prognosis, which can be further stratified by the SMI, providing valuable insights for patient management and potential therapeutic interventions.
Databáze: Directory of Open Access Journals